You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023244029
Dec 202314408
Jan 202487012
Feb 20246401
Mar 2024102015
Apr 2024312016
May 202413609
Jun 20248001
Jul 20245406
Aug 20245008
Sep 20245402
Oct 202476010
Nov 20249007
Dec 2024184011
Jan 20258607
Feb 20251007
Mar 2025007
Apr 2025005
May 2025005
Jun 2025106
Total17740172